Allergan (AGN) Posts Q3 EPS of $1.13, Topping Street; Guides FY09
AGN Hot Sheet
Revenue Growth %: -99.9%Financial Fact:
Selling, general and administrative: 585.1M
Today's EPS Names:
SAPX, ECTY, TRNS, More
Allergan (NYSE: AGN) reports Q3 EPS of $1.13, versus the analyst estimate of $0.70. Revenue for the quarter was $1.13 billion, which compares to the estimate of $1.08 billion.
Sees FY09 sales of $4.35-$4.4 billion, and EPS of $2.75 - $2.77/share.
Sees FY09 sales of $4.35-$4.4 billion, and EPS of $2.75 - $2.77/share.
You May Also Be Interested In
- Nordson Corp (NDSN) Misses Q2 EPS by 3c; Guides Q3
- Casual Male Retail Group (CMRG) Reports In-Line Q1 EPS; Comps Up 2%; Reaffirms
- Daqo New Energy (DQ) Posts Q1 Loss of 39c/Share; Guides Q2 Shipments
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
